Natco Pharma Share Price Drops After USFDA Issues 7 Observations
We saw Natco Pharma’s share price slide after the U.S. Food and Drug Administration (USFDA) raised seven observations at its Hyderabad facility. This isn’t just a small hiccup; regulatory scrutiny from the USFDA often sets off alarm bells for investors. Natco has responded with confidence, saying it will fix the issues. But the market’s reaction…